Publications by authors named "Danforth P Miller"

Claim this Profile
M
Molecular Prosthetics and CFTR Modulators Additively Increase Secretory HCO Flux in Cystic Fibrosis Airway Epithelia.
Nohemy Celis, Danforth P Miller, Thomas E Tarara, Jeffry G Weers, Ian M Thornell

ACS Chem Biol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular prosthetics and CFTR modulators additively increase secretory HCO flux in cystic fibrosis airway epithelia.
Nohemy Celis, Danforth P Miller, Thomas E Tarara, Jeffry G Weers, Ian M Thornell

bioRxiv· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting of Inhaled Therapeutics to the Small Airways: Nanoleucine Carrier Formulations.
Danforth P Miller, Thomas E Tarara, Jeffry G Weers

Pharmaceutics· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Post-inhalation cough with therapeutic aerosols: Formulation considerations.
Sawittree Sahakijpijarn, Hugh D C Smyth, Danforth P Miller, Jeffry G Weers

Adv Drug Deliv Rev· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimizing Spray-Dried Porous Particles for High Dose Delivery with a Portable Dry Powder Inhaler.
Yoen-Ju Son, Danforth P Miller, Jeffry G Weers

Pharmaceutics· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Idealhalers Versus Realhalers: Is It Possible to Bypass Deposition in the Upper Respiratory Tract?
Jeffry G Weers, Yoen-Ju Son, Mark Glusker, Alfred Haynes, Daniel Huang, Danforth P Miller

J Aerosol Med Pulm Drug Deliv· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spray-Dried PulmoSphere™ Formulations for Inhalation Comprising Crystalline Drug Particles.
Jeffry G Weers, Danforth P Miller, Thomas E Tarara

AAPS PharmSciTech· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Ciprofloxacin Dry Powder for Inhalation (ciprofloxacin DPI): Technical design and features of an efficient drug-device combination.
Pamela J McShane, Jeffry G Weers, Thomas E Tarara, Alfred Haynes, Preeti Durbha, Danforth P Miller

Pulm Pharmacol Ther· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Physical Characterization of Tobramycin Inhalation Powder: II. State Diagram of an Amorphous Engineered Particle Formulation.
Danforth P Miller, Trixie Tan, John Nakamura, Richard J Malcolmson, Thomas E Tarara

Mol Pharm· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Formulation Design of Dry Powders for Inhalation.
Jeffry G Weers, Danforth P Miller

J Pharm Sci· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Physical Characterization of Tobramycin Inhalation Powder: I. Rational Design of a Stable Engineered-Particle Formulation for Delivery to the Lungs.
Danforth P Miller, Trixie Tan, Thomas E Tarara, John Nakamura, Richard J Malcolmson

Mol Pharm· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advances in Respiratory and Nasal Drug Delivery.
David Lechuga-Ballesteros, Danforth P Miller

Mol Pharm· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Solid-state stability of spray-dried insulin powder for inhalation: chemical kinetics and structural relaxation modeling of Exubera above and below the glass transition temperature.
Negar Sadrzadeh, Danforth P Miller, David Lechuga-Ballesteros, Nancy J Harper, Cynthia L Stevenson

J Pharm Sci· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trileucine improves aerosol performance and stability of spray-dried powders for inhalation.
David Lechuga-Ballesteros, Chatan Charan, Cheryl L M Stults, Cynthia L Stevenson, Danforth P Miller

J Pharm Sci· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prediction of the onset of crystallization of amorphous sucrose below the calorimetric glass transition temperature from correlations with mobility.
Chandan Bhugra, Shailaja Rambhatla, Aziz Bakri, Sarma P Duddu, Danforth P Miller

J Pharm Sci· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rapid assessment of the structural relaxation behavior of amorphous pharmaceutical solids: effect of residual water on molecular mobility.
Danforth P Miller, David Lechuga-Ballesteros

Pharm Res· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimisation of powders for pulmonary delivery using supercritical fluid technology.
Mahboob Rehman, Boris Y Shekunov, Peter York, David Lechuga-Ballesteros, Danforth P Miller

Eur J Pharm Sci· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Physical stability of salmon calcitonin spray-dried powders for inhalation.
Hak-Kim Chan, Andrew R Clark, Jane C Feeley, Mei-Chang Kuo, S Russ Lehrman, Danforth P Miller

J Pharm Sci· March 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Microcalorimetric measurement of the interactions between water vapor and amorphous pharmaceutical solids.
David Lechuga-Ballesteros, Aziz Bakri, Danforth P Miller

Pharm Res· February 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis